{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The process of approving drugs, with the huge bets placed on their outcome, has always been a fertile ground for potential insider trading. A hint of success in a clinical trial can send shares of a biotechnology company surging. The best-known example is that of Samuel D. Waksal, the former chief executive of ImClone Systems, who pleaded guilty to charges that he tipped off family members to sell shares shortly before an unfavorable regulatory ruling.", "headline": {"main": "Today's Insider Trading Suspect May Wear a Lab Coat", "kicker": "MARKET PLACE"}, "abstract": "Securities and Exchange Commission is taking closer look at whether doctors participating in clinical trials with drug companies are accepting money to talk to analysts and investors about confidential results; probe could have broad implications for investors in drug companies, in particular hedge funds, which are aggressive consumers of information; inquiry could also have impact on analysts seeking to do independent research and new breed of research firms that facilitate primary research by connecting investors with specialists in particular field; Sen Charles E Grassley, chairman of Finance Committee, calls on Justice Department as well as SEC to investigate issue of payment for drug trial results; photo (Market Place column) (M)", "print_page": "1", "word_count": 886, "_id": "4fd285f78eb7c8105d856a05", "snippet": "Scrutiny of trading based on advance knowledge of drug trial results may be moving from executive suites to clinics.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/08/09/business/09place.html", "multimedia": [{"url": "imagepages/2005/08/09/business/09place_CA0ready.html", "rank": "1", "height": 325, "width": 250, "legacy": {"MultimediaPopupWidth1": "250", "MultimediaUrl1": "imagepages/2005/08/09/business/09place_CA0ready.html", "MultimediaPopupHeight1": "325", "MultimediaType1": "Image"}, "type": "Image"}], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "MARKET PLACE (TIMES COLUMN)"}, {"name": "persons", "value": "GRASSLEY, CHARLES E"}, {"name": "organizations", "value": "SECURITIES AND EXCHANGE COMMISSION"}, {"name": "subject", "value": "SECURITIES AND COMMODITIES VIOLATIONS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "STOCKS AND BONDS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "HEDGE FUNDS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jenny", "rank": 1, "lastname": "ANDERSON"}], "original": "By JENNY ANDERSON"}, "document_type": "article", "pub_date": "2005-08-09T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "After a year of debate over whether antidepressant drugs increase the risk of suicide, a new study finds that a standard brand of talk therapy may offer the best chance to save those at the highest risk of taking their own lives. The therapy cut almost by half the risk of suicide attempts in extremely suicidal patients, many of whom were already taking drugs for depression, the researchers found.", "headline": {"main": "Talk Therapy Succeeds In Reducing Suicide Risk"}, "abstract": null, "print_page": "7", "word_count": 674, "_id": "4fd285f78eb7c8105d8569f6", "snippet": "A new study finds that a standard brand of talk therapy may offer the best chance to save those at the highest risk of taking their own lives.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/08/09/health/09suic.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Benedict", "rank": 1, "lastname": "CAREY"}], "original": "By BENEDICT CAREY"}, "document_type": "article", "pub_date": "2005-08-09T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 2, "offset": 0, "time": 31}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}